Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Introducing UNICORN Signals

Powered By EquityPandit
4.5 Google Ratings

Alivus Life Sciences Ltd

NSE :ALIVUS   BSE :543322  Sector : Pharmaceuticals
Buy, Sell or Hold ALIVUS? Ask The Analyst
Check Gift Nifty (SGX Nifty) Live Price to predict the market.

BSE
Apr 09, 00:00

940.65

-64.95 (-6.46%)

prev close

1005.60

OPEN PRICE

995.15

volume

2186

Today's low / high

935.00 / 997.45

52 WK low / high

743.60 / 1335.00

bid price (qty)

0 (0)

offer price (qty)

0 (0)

NSE

prev close

open price

volume

Today's' low / high

52 WK low / high

bid price (qty)

offer price (qty)

08 Apr
1005.95
(3.37%)
07 Apr
973.15
(-2.79%)
04 Apr
1001.05
(-6.04%)
03 Apr
1065.40
(0.51%)
02 Apr
1060.00
(2.53%)
01 Apr
1033.80
(-4.38%)
28 Mar
1081.15
(1.84%)
27 Mar
1061.65
(5.71%)
26 Mar
1004.35
(-2.16%)
25 Mar
1026.55
(-3.53%)
24 Mar
1064.10
(-3.32%)
21 Mar
1100.60
(-2.89%)
20 Mar
1133.40
(4.89%)
19 Mar
1080.55
(1.39%)
18 Mar
1065.75
(4.25%)
17 Mar
1022.30
(-0.17%)
13 Mar
1024.00
(0.64%)
12 Mar
1017.45
(3.33%)
11 Mar
984.70
(-5.03%)
10 Mar
1036.80
(-3.91%)
07 Mar
1078.95
(1.33%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish
Medium Term Investors

Very Bearish
Long Term Investors

Neutral

Moving Averages

5 DMA
Bearish

1021.15

10 DMA
Bearish

1031.61

20 DMA
Bearish

1042.43

50 DMA
Bearish

1067.06

100 DMA
Bearish

1058.62

200 DMA
Bearish

1040.88


Intraday Support and Resistance
(Based on Pivot Points) undefined | BSE : 940.65

Updated On Apr 08, 2025 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1081.26 1053.08 1020.18 - -
R2 1053.08 1033.31 1015.44 1054.24 -
R1 1029.51 1021.1 1010.69 1031.83 1041.3
P 1001.33 1001.33 1001.33 1002.49 1007.23
S1 977.76 981.56 1001.21 980.08 989.55
S2 949.58 969.35 996.46 950.74 -
S3 926.01 949.58 991.72 - -

Key Metrics

Shareholding Pattern

  75% Total Promoter Holding
3.23% Mutual Fund Holdings
6.74% FIIs
13.4% Non Institution
0.22% Insurance Companies
0% Custodians
1.41% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Alivus Life Sciences Ltd Quaterly Results


INCOME
PROFIT
EPS

Alivus Life Sciences Ltd Quaterly Results


INCOME574.5 539.73 594.11 515.41 652.3
PROFIT118.77 97.94 111.48 95.32 136.96
EPS9.69 7.99 9.1 7.78 11.18

Profit & Loss (Figures in Rs. Crores)


Alivus Life Sciences Ltd Profit & Loss


INCOME
PROFIT
EPS

Alivus Life Sciences Ltd Profit & Loss


Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 0.2 1188.45 1553.94 1956.68 2096.59 2274.62 2351.82
PROFIT -0.43 196.13 314.01 352.02 419.27 467.37 471.42
EPS -434 997.92 1597.44 358.76 34.17 38.11 38.43

Balance Sheet (Figures in Rs. Crores)
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
SOURCES OF FUNDS :
Share Capital 24.5124.5124.511.961.961.960.01
Reserves Total 2,307.822,113.72,029.81750.79399.7386.17-1.41
Total Shareholders Funds2,332.332,138.212,054.32752.75401.6988.13-1.4
Unsecured Loans 17.1519.362.8800.020.020
Total Debt17.1519.362.8800.020.020
Other Liabilities15.777.8700000
Total Liabilities2,365.252,165.442,057.2752.75401.7188.15-1.4
APPLICATION OF FUNDS :
Gross Block 1,012.33936.48705.53651.9594.82475.570
Less : Accumulated Depreciation 207.26155.85115.7779.148.5819.260
Net Block 805.07780.63589.76572.8546.24456.310
Capital Work in Progress105.9961.6296.9614.110.7380.390
Investments 0.080.080.080.080.080.080
Inventories 666.59604.17516.24513.42412.78400.840.04
Sundry Debtors 765.43806.77673.49619.5638.63448.090.03
Cash and Bank Balance301.59309.4512.16115.6102.060.01
Loans and Advances 182.38130.0162.69150.5298.7179.70.01
Total Current Assets1,9161,850.341,764.591,399.041,160.12930.690.08
Current Liabilities 424.35479.53355.881,187.851,285.11,3641.47
Provisions 12.0314.7526.4433.622.3416.40.01
Total Current Liabilities & Provisions436.38494.28382.321,221.441,307.441,380.391.48
Net Current Assets1,479.621,356.071,382.27177.59-147.33-449.7-1.4
Deferred Tax Assets4.551.811.072.030.132.290
Deferred Tax Liability53.3444.2532.5724.9116.589.140
Net Deferred Tax-48.79-42.44-31.5-22.88-16.45-6.850
Other Assets23.299.4919.6311.068.447.920
Total Assets2,365.252,165.452,057.2752.75401.7288.15-1.4
Contingent Liabilities4.822.222.222.222.222.760

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...631.29
Depreciation53.45
Interest (Net)-10.48
P/L on Sales of Assets0.7
Prov. and W/O (Net)31.48
P/L in Forex-0.27
Total Adjustments (PBT and Ext...79.27
Operating Profit before Workin...710.56
Trade and 0ther Receivables-17.33
Inventories-82.63
Trade Payables-34.12
Total Adjustments (OP before W...-134.08
Cash Generated from/(used in) ...576.48
Direct Taxes Paid-162.96
Total Adjustments(Cash Generat...-162.96
Cash Flow before Extraordinary...413.52
Net Cash from Operating Activi...413.52
Purchased of Fixed Assets-128.97
Sale of Fixed Assets0.47
Interest Received12.02
Net Cash used in Investing Act...-116.48
Of Financial Liabilities-2.21
Dividend Paid-275.69
Interest Paid-1.55
Net Cash used in Financing Act...-279.44

Company Details

Registered Office
AddressPlot No. 170-172 Chandramouli,
Industrial Est.Mohol Bazarpeth
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Registrars
AddressPlot No. 170-172 Chandramouli
CitySolapur
StateMaharashtra
Pin Code413213
Tel. No.91-2189-234456/234246
Fax. No.
Emailcomplianceofficer@glenmarklifesciences.com
Internethttp://www.glenmarklifesciences.com
Management
Name Designation
Yasir Yusufali RawjeeManaging Director & CEO
Vinod NaikExecutive Director
Manju AgarwalIndependent Non Exe. Director
Taruvai Laxminarayanan EaswarIndependent Non Exe. Director
HIREN KARSANBHAI PATELChairman (Non-Executive)
KAUSHIKBHAI NANDUBHAI PATELIndependent Director
Savan GodialwalaIndependent Director
Rudalf CorrieaCompany Sec. & Compli. Officer